Mark Newcomer Sells 40,000 Shares of Paysign, Inc. (NASDAQ:PAYS) Stock

Posted by Tyrone Williams on Nov 22nd, 2024

Paysign, Inc. (NASDAQ:PAYS – Get Free Report) CEO Mark Newcomer sold 40,000 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $3.24, for a total value of $129,600.00. Following the sale, the chief executive officer now owns 9,296,886 shares in the company, valued at approximately $30,121,910.64. This represents a 0.43 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Mark Newcomer also recently made the following trade(s):

On Wednesday, November 20th, Mark Newcomer sold 25,000 shares of Paysign stock. The shares were sold at an average price of $3.27, for a total value of $81,750.00.
On Wednesday, October 23rd, Mark Newcomer sold 36,000 shares of Paysign stock. The shares were sold at an average price of $3.66, for a total transaction of $131,760.00.
On Monday, October 21st, Mark Newcomer sold 22,000 shares of Paysign stock. The stock was sold at an average price of $3.75, for a total transaction of $82,500.00.
On Monday, September 23rd, Mark Newcomer sold 50,000 shares of Paysign stock. The shares were sold at an average price of $4.25, for a total transaction of $212,500.00.
On Thursday, September 19th, Mark Newcomer sold 1,500 shares of Paysign stock. The shares were sold at an average price of $4.50, for a total transaction of $6,750.00.
On Friday, September 13th, Mark Newcomer sold 1,500 shares of Paysign stock. The stock was sold at an average price of $4.50, for a total transaction of $6,750.00.

Paysign Trading Up 1.2 %

Paysign stock opened at $3.43 on Friday. Paysign, Inc. has a 1-year low of $2.22 and a 1-year high of $5.59. The firm has a market cap of $183.68 million, a P/E ratio of 22.87 and a beta of 0.95. The firm has a 50-day moving average of $3.83 and a 200-day moving average of $4.29.

Paysign (NASDAQ:PAYS – Get Free Report) last announced its earnings results on Tuesday, November 5th. The company reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.02. The firm had revenue of $15.26 million for the quarter, compared to analyst estimates of $14.96 million. Paysign had a net margin of 14.28% and a return on equity of 30.64%. During the same quarter in the previous year, the firm posted $0.02 EPS. Research analysts forecast that Paysign, Inc. will post 0.21 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Barrington Research restated an “outperform” rating and set a $7.00 target price on shares of Paysign in a report on Monday, November 4th.

Read Our Latest Stock Report on PAYS

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC grew its position in Paysign by 25.0% during the 2nd quarter. Renaissance Technologies LLC now owns 1,504,380 shares of the company’s stock valued at $6,484,000 after purchasing an additional 301,000 shares during the last quarter. Royce & Associates LP bought a new stake in shares of Paysign during the 3rd quarter valued at about $814,000. Rhumbline Advisers grew its position in shares of Paysign by 25.1% during the 2nd quarter. Rhumbline Advisers now owns 35,835 shares of the company’s stock valued at $154,000 after acquiring an additional 7,190 shares during the period. Joule Financial LLC bought a new position in Paysign in the 3rd quarter worth $1,478,000. Finally, Vanguard Group Inc. lifted its position in Paysign by 3.0% during the first quarter. Vanguard Group Inc. now owns 1,649,043 shares of the company’s stock valued at $6,035,000 after purchasing an additional 48,489 shares in the last quarter. Hedge funds and other institutional investors own 25.89% of the company’s stock.

About Paysign

(Get Free Report)

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.